Waxaa la aasaasay 2009, JYMed waa shirkad dawooyin ah oo ku taal Shiinaha oo isku xirta R&D, wax-soo-saarka, ganacsiga, iyo horumarinta gaarka ah iyo soosaarka alaabada peptide. Shirkaddu waxay leedahay qiyaastii 570 shaqaale ah, oo leh koox maareyn xudun u ah oo ka kooban xirfadlayaal leh khibradda daawooyinka iyo in ka badan 20 sano oo waayo-aragnimo ah warshadaha peptide. JYMed waxay ka shaqeysaa hal xarun cilmi baaris iyo laba tas-hiilaad wax soo saar oo waaweyn, iyadoo ku gaareysa awoodda wax-soo-saarka miisaanka badan ee peptides, iyada oo u dhiganta hoggaamiye warshadeed.
Horudhaca JYMed, oo ah FDA-da Maraykanka ayaa baadhay soo saaraha peptide. Alaabooyinka la soo bandhigay: peptide cosemtic, peptide APIs, peptides caadadii, sida, Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-CU, Acetyl Hexapeptide-8, iwm. Si aad wax badan u ogaato, fadlan la xidhiidh
Email: jymed@jymedtech.com